PMCB — PHARMACYTE BIOTECH INC

Ownership history in SIMPLEX TRADING, LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which SIMPLEX TRADING, LLC reported a position in PHARMACYTE BIOTECH INC (PMCB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 25,834 +24,734 +2248.5% 0.00% $19K $0.72
2025 Q3 REDUCED 1,100 -46,049 -97.7% 0.00% $1K $0.97
2023 Q2 REDUCED 47,149 -86,051 -64.6% 0.00% $134K $2.86
2023 Q1 ADDED 133,200 +69,592 +109.4% 0.00% $387K $2.91
2022 Q4 REDUCED 63,608 -1,812 -2.8% 0.00% $186K $2.93
2022 Q3 ADDED 65,420 +10,493 +19.1% 0.00% $157K $2.40
2022 Q2 INITIATED 54,927 — — 0.00% $123K $2.24
% of Fund (quarterly)    PMCB price (monthly, adj. close)

Other funds also holding PMCB

As of 2025 Q4 — sorted by position size

SABBY MANAGEMENT, LLC 3Y 7Y 0.1% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0% HRT FINANCIAL LP 3Y 7Y 0.0% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% Schonfeld Strategic Advisors LLC 3Y 7Y 0.0% CITADEL ADVISORS LLC 3Y 7Y 0.0% CITADEL ADVISORS LLC 3Y 7Y 0.0%
← Back to SIMPLEX TRADING, LLC Holdings